Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""The American Journal of Medicine"" wg kryterium: Wszystkie pola


Wyświetlanie 1-15 z 15
Tytuł :
Prediction of significant bleeding during vitamin K antagonist treatment for venous thromboembolism in outpatients.
Autorzy :
Martinez C; Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
Katholing A; Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
Wallenhorst C; Institute for Epidemiology, Statistics and Informatics GmbH, Frankfurt, Germany.
Cohen AT; Guys and St Thomas' NHS Foundation Trust, Haematological Medicine, London, United Kingdom.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 May; Vol. 189 (3), pp. 524-533. Date of Electronic Publication: 2020 Jan 29.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Hemorrhage/*etiology
Venous Thromboembolism/*drug therapy
Vitamin K/*antagonists & inhibitors
Female ; Humans ; Male ; Middle Aged ; Outpatients
Czasopismo naukowe
Tytuł :
Pro-inflammatory cytokines favor the emergence of ETV6-RUNX1-positive pre-leukemic cells in a model of mesenchymal niche.
Autorzy :
Beneforti L; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Dander E; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Bresolin S; Dipartimento della Salute della Donna e del Bambino, University of Padua, Padua, Italy.
Bueno C; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.
Acunzo D; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Bertagna M; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Ford A; Centre for Evolution and Cancer, The Institute of Cancer Research, London, UK.
Gentner B; San Raffaele Telethon Institute for Gene Therapy (SR-TIGET), IRCCS San Raffaele Scientific Institute, Milan, Italy.
Kronnie GT; Dipartimento della Salute della Donna e del Bambino, University of Padua, Padua, Italy.
Vergani P; Dipartimento di Ostetricia, MBBM Foundation, Monza, Italy.
Menéndez P; Department of Biomedicine, School of Medicine, Josep Carreras Leukemia Research Institute, University of Barcelona, Barcelona, Spain.; Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer (CIBER-ONC), ISCIII, Barcelona, Spain.
Biondi A; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.; Clinica Pediatrica, MBBM Foundation, University of Milano-Bicocca, Monza, Italy.
D'Amico G; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Palmi C; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Cazzaniga G; Centro Ricerca Tettamanti, University of Milano-Bicocca, MBBM Foundation, Monza, Italy.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Jul; Vol. 190 (2), pp. 262-273. Date of Electronic Publication: 2020 Mar 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Core Binding Factor Alpha 2 Subunit/*metabolism
Cytokines/*metabolism
Mesenchymal Stem Cells/*metabolism
Oncogene Proteins, Fusion/*metabolism
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*metabolism
Core Binding Factor Alpha 2 Subunit/genetics ; Humans ; Oncogene Proteins, Fusion/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Translocation, Genetic
Czasopismo naukowe
Tytuł :
Presentation clinical, haematological and immunophenotypic features of 1081 patients with GPI-deficient (paroxysmal nocturnal haemoglobinuria) cells detected by flow cytometry.
Autorzy :
Richards SJ; Section of Experimental Haematology and Immunology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, UK.; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Dickinson AJ; Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Cullen MJ; Haematopathology and Oncology Diagnostic Service (HODS), Box 234, Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK.
Griffin M; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Munir T; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
McKinley C; Section of Experimental Haematology and Immunology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, UK.
Mitchell LD; Department of Haematology, University Hospital, Monklands, Airdrie, UK.
Newton DJ; Section of Experimental Haematology and Immunology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, UK.
Arnold L; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Hill A; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Hillmen P; Section of Experimental Haematology and Immunology, Leeds Institute of Medical Research at St. James's, School of Medicine, University of Leeds, Leeds, UK.; Department of Haematology, Leeds Teaching Hospitals NHS Trust, Level 3 Bexley Wing, St James's University Hospital, Leeds, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Jun; Vol. 189 (5), pp. 954-966. Date of Electronic Publication: 2020 Feb 27.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Glycosylphosphatidylinositols/*deficiency
Hemoglobinuria, Paroxysmal/*blood
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Anemia, Aplastic/etiology ; Anemia, Hemolytic/etiology ; CD55 Antigens/deficiency ; CD59 Antigens/deficiency ; Child ; Child, Preschool ; Clonal Evolution ; Clone Cells/pathology ; Disease Progression ; Female ; Flow Cytometry ; Hemoglobinuria, Paroxysmal/complications ; Hemoglobinuria, Paroxysmal/genetics ; Hemoglobinuria, Paroxysmal/pathology ; Humans ; Immunophenotyping ; Infant ; Lymphocytes/pathology ; Male ; Middle Aged ; Myeloproliferative Disorders/etiology ; Neutrophils/pathology ; Receptors, Transferrin/blood ; Retrospective Studies ; Thrombosis/etiology ; Young Adult
Czasopismo naukowe
Tytuł :
Incidence and outcomes of heparin-induced thrombocytopenia in solid malignancy: an analysis of the National Inpatient Sample Database.
Autorzy :
Kumar R; Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Bhandari S; Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Singh SRK; Division of Hematology and Oncology, Henry Ford Cancer Institute, Henry Ford Hospital, Detroit, MI, USA.
Malapati S; Division of Hematology and Oncology, Van Elslander Cancer Center, Ascension St. John Hospital and Medical Center, Detroit, MI, USA.
Cisak KI; Division of Medical Oncology and Hematology, James Graham Brown Cancer Center, University of Louisville, Louisville, KY, USA.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 May; Vol. 189 (3), pp. 543-550. Date of Electronic Publication: 2020 Jan 28.
Typ publikacji :
Journal Article
MeSH Terms :
Heparin/*adverse effects
Neoplasms/*complications
Thrombocytopenia/*chemically induced
Aged ; Databases, Factual ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Neoplasms/blood ; United States
Czasopismo naukowe
Tytuł :
Improved survival after offspring donor transplant compared with older aged-matched siblings for older leukaemia patients.
Autorzy :
Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center hematology, Soochow University, Suzhou, China.
Liu QF; Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, Beijing.
Wu DP; The first affiliated hospital of Soochow University, Suzhou, Jiangsu, China.; Collaborative Innovation Center hematology, Soochow University, Suzhou, China.
Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Lu SY; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.
Ma X; The first affiliated hospital of Soochow University, Suzhou, Jiangsu, China.
Huang F; Peking-Tsinghua Center for Life Sciences, Beijing, China.
Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing, China.; Collaborative Innovation Center hematology, Peking University, Beijing, China.; The first affiliated hospital of Soochow University, Suzhou, Jiangsu, China.; Collaborative Innovation Center hematology, Soochow University, Suzhou, China.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (1), pp. 153-161. Date of Electronic Publication: 2019 Nov 07.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hematopoietic Stem Cell Transplantation*
Leukemia*/mortality
Leukemia*/therapy
Siblings*
Tissue Donors*
Graft vs Host Disease/*mortality
Acute Disease ; Age Factors ; Allografts ; Female ; Follow-Up Studies ; Graft vs Host Disease/etiology ; Humans ; Incidence ; Male ; Middle Aged ; Retrospective Studies ; Risk Factors ; Time Factors
Czasopismo naukowe
Tytuł :
Are we assessing venous thromboembolism (VTE) risk appropriately for hospitalised medical patients? The National VTE Risk Assessment Tool versus Padua Prediction Score.
Autorzy :
Chandra D; Haematology, University Hospital of North Midlands NHS Trust, Stoke-on-Trent, UK.
Dabhi K; Health Informatics, University Hospital Birminmgham NHS Foundation Trust, Birmingham, UK.
Lester W; Haematology, University Hospital Birminmgham NHS Foundation Trust, Birmingham, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (1), pp. e16-e18. Date of Electronic Publication: 2020 Jan 24.
Typ publikacji :
Letter; Comment
MeSH Terms :
Hematology*
Venous Thromboembolism*/diagnosis
Venous Thromboembolism*/epidemiology
Venous Thromboembolism*/etiology
Anticoagulants ; Cost-Benefit Analysis ; Humans ; Risk Assessment ; Risk Factors
Opinia redakcyjna
Tytuł :
Serum soluble VSIG4 as a surrogate marker for the diagnosis of lymphoma-associated hemophagocytic lymphohistiocytosis.
Autorzy :
Yuan S; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Wang Y; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Luo H; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Jiang Z; Laboratory of Oncology, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Qiao B; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Jiang Y; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Hu Y; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Cheng Y; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Chen X; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Gong W; Department of Surgery, Second Affiliated Hospital of School of Medicine, Zhejiang University, Hangzhou, Zhejiang, China.
Huang Y; Department of Pathology, The PLA 81st Group Army Hospital, Zhangjiakou, China.
Zhao W; Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China.
Luo D; Beijing Institute of Microbiology and Epidemiology, Beijing, China.
Liu B; Laboratory of Oncology, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Su H; Department of Lymphoma, Head and Neck Cancer, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Zhou J; Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Song S; Department of Laboratory Medicine, The Fifth Medical Center, Chinese PLA General Hospital (Former 307th hospital of the PLA), Beijing, China.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Apr; Vol. 189 (1), pp. 72-83. Date of Electronic Publication: 2020 Jan 21.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Lymphohistiocytosis, Hemophagocytic*/blood
Lymphohistiocytosis, Hemophagocytic*/diagnosis
Lymphohistiocytosis, Hemophagocytic*/etiology
Lymphoma*/blood
Lymphoma*/complications
Lymphoma*/diagnosis
Biomarkers, Tumor/*blood
Neoplasm Proteins/*blood
Receptors, Complement/*blood
Adult ; Aged ; Aged, 80 and over ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Retrospective Studies
Czasopismo naukowe
Tytuł :
A randomised controlled trial of extended anticoagulation treatment versus standard treatment for the prevention of recurrent venous thromboembolism (VTE) and post-thrombotic syndrome in patients being treated for a first episode of unprovoked VTE (the ExACT study).
Autorzy :
Bradbury C; School of Cellular and Molecular Medicine, University of Bristol, Bristol, UK.
Fletcher K; Institute of Applied Health Research, The University of Birmingham, Birmingham, UK.
Sun Y; Institute of Applied Health Research, The University of Birmingham, Birmingham, UK.
Heneghan C; Nuffield Department of Primary Care Health Sciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Gardiner C; Haemostasis Research Unit (HRU), Department of Haematology, University College London, London, UK.
Roalfe A; Nuffield Department of Primary Care Health Sciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Hardy P; Institute of Applied Health Research, The University of Birmingham, Birmingham, UK.
McCahon D; Centre for Academic Primary Care, Bristol Medical School, University of Bristol, Bristol, UK.
Heritage G; Institute of Applied Health Research, The University of Birmingham, Birmingham, UK.
Shackleford H; Institute of Applied Health Research, The University of Birmingham, Birmingham, UK.
Hobbs FR; Nuffield Department of Primary Care Health Sciences, Medical Sciences Division, University of Oxford, Oxford, UK.
Fitzmaurice D; Unit of Academic Primary Care, Warwick Medical School, University of Warwick, Coventry, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Mar; Vol. 188 (6), pp. 962-975. Date of Electronic Publication: 2019 Nov 12.
Typ publikacji :
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Anticoagulants/*therapeutic use
Venous Thromboembolism/*drug therapy
Aged ; Anticoagulants/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Recurrence ; Venous Thromboembolism/prevention & control
Czasopismo naukowe
Tytuł :
Emergencies in haematology: tumour lysis syndrome.
Autorzy :
Durani U; Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Hogan WJ; Department of Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2020 Feb; Vol. 188 (4), pp. 494-500. Date of Electronic Publication: 2019 Nov 27.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Fluid Therapy*
Tumor Lysis Syndrome*/blood
Tumor Lysis Syndrome*/mortality
Tumor Lysis Syndrome*/therapy
Allopurinol/*therapeutic use
Hematologic Neoplasms/blood ; Hematologic Neoplasms/mortality ; Hematologic Neoplasms/therapy ; Humans ; Risk Factors
Czasopismo naukowe
Tytuł :
A 24-year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom.
Autorzy :
Sharpley FA; National Amyloidosis Centre, University College London, London, UK.
Petrie A; Biostatistics Unit, UCL Eastman Dental Institute, London, UK.
Mahmood S; National Amyloidosis Centre, University College London, London, UK.
Sachchithanantham S; National Amyloidosis Centre, University College London, London, UK.
Lachmann HJ; National Amyloidosis Centre, University College London, London, UK.
Gillmore JD; National Amyloidosis Centre, University College London, London, UK.
Whelan CJ; National Amyloidosis Centre, University College London, London, UK.
Fontana M; National Amyloidosis Centre, University College London, London, UK.
Martinez-Naharro A; National Amyloidosis Centre, University College London, London, UK.
Quarta C; National Amyloidosis Centre, University College London, London, UK.
Hawkins PN; National Amyloidosis Centre, University College London, London, UK.
Wechalekar AD; National Amyloidosis Centre, University College London, London, UK.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Dec; Vol. 187 (5), pp. 642-652. Date of Electronic Publication: 2019 Aug 13.
Typ publikacji :
Journal Article
MeSH Terms :
Hematopoietic Stem Cell Transplantation/*methods
Immunoglobulin Light-chain Amyloidosis/*therapy
Adult ; Aged ; Female ; Hematopoietic Stem Cell Mobilization/methods ; Hematopoietic Stem Cell Transplantation/adverse effects ; Hematopoietic Stem Cell Transplantation/mortality ; Humans ; Immunoglobulin Light-chain Amyloidosis/mortality ; Kaplan-Meier Estimate ; Male ; Middle Aged ; Proportional Hazards Models ; Retrospective Studies ; Transplantation Conditioning/methods ; Treatment Outcome ; United Kingdom/epidemiology
Czasopismo naukowe
Tytuł :
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease.
Autorzy :
Alberelli MA; Unità Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario Agostino Gemeli IRCCS, Roma, Italy.
Bacci M; Centro Trombosi e Malattie Emorragiche, Humanitas Clinical and Research Centre IRCCS, Rozzano (Mi), Italy.
Marchetti M; Department of Immunohaematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Ferrazzi P; Centro Trombosi e Malattie Emorragiche, Humanitas Clinical and Research Centre IRCCS, Rozzano (Mi), Italy.
Dragani A; Rare Blood Disease Centre, Department of Haematology, Santo Spirito Hospital, Pescara, Italy.
Gamba S; Department of Immunohaematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.
Landolfi R; Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Roma, Italy.
Falanga A; Department of Immunohaematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy.; School of Medicine and Surgery, Università di Milano Bicocca, Monza, Italy.
Lodigiani C; Centro Trombosi e Malattie Emorragiche, Humanitas Clinical and Research Centre IRCCS, Rozzano (Mi), Italy.; Department of Biomedical Sciences, Humanitas University, Milano, Italy.
De Candia E; Unità Malattie Emorragiche e Trombotiche, Fondazione Policlinico Universitario Agostino Gemeli IRCCS, Roma, Italy.; Istituto di Medicina Interna e Geriatria, Università Cattolica del Sacro Cuore, Roma, Italy.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Dec; Vol. 187 (5), pp. e87-e91. Date of Electronic Publication: 2019 Oct 14.
Typ publikacji :
Case Reports; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Albinism/*drug therapy
Autoimmune Diseases/*drug therapy
Hemorrhagic Disorders/*drug therapy
Hermanski-Pudlak Syndrome/*drug therapy
Immunosuppressive Agents/*therapeutic use
Rituximab/*therapeutic use
Thrombasthenia/*drug therapy
Adult ; Aged ; Albinism/blood ; Autoimmune Diseases/blood ; Female ; Hemorrhagic Disorders/blood ; Hermanski-Pudlak Syndrome/blood ; Humans ; Male ; Platelet Count ; Thrombasthenia/blood
SCR Disease Name :
Albinism with hemorrhagic diathesis and pigmented reticuloendothelial cells
Czasopismo naukowe
Tytuł :
Outcome of CARE: a 6-year national registry of acquired haemophilia A in China.
Autorzy :
Sun B; State Key Laboratory of Experimental Haematology, National Clinical Research Centre for Haematological Disorders, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China.
Xue F; State Key Laboratory of Experimental Haematology, National Clinical Research Centre for Haematological Disorders, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China.
Feng Y; Department of Haematology, Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Sun J; Nanfang Hospital, Nanfang Medical University, Guangzhou, China.
Yu Z; Department of Haematology, The First Affiliated Hospital of Soochow University, Suzhou, China.
Hou M; Department of Haematology, Qilu Hospital, Shandong University, Jinan, Shandong, China.
Zhang J; Department of Haematology, Key Laboratory of Haematology of Hebei Province, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, China.
Zeng X; Department of Blood Transfusion, The Affiliated Hospital of Guizhou University, Guiyang, China.
Zhao Y; Department of Haematology, Peking Union Medical College Hospital, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, China.
Lian S; Department of Haematology, Dalian Municipal Central Hospital, Affiliated Hospital of Dalian Medical University, Dalian, China.
Huang M; Fujian Institute of Haematology, Fujian Medical University Union Hospital, Fuzhou, China.
Niu T; Department of Haematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Cui Z; The Affiliated Hospital of Qingdao University, Qingdao, China.
Wu J; Department of Haematology, Anhui Provincial Hospital, Anhui Medical University, Hefei, China.
Yang R; State Key Laboratory of Experimental Haematology, National Clinical Research Centre for Haematological Disorders, Institute of Haematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin Laboratory of Blood Disease Gene Therapy, CAMS Key Laboratory of Gene Therapy for Blood Diseases, Tianjin, China.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Dec; Vol. 187 (5), pp. 653-665. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Hemophilia A/*diagnosis
Hemophilia A/*drug therapy
Adult ; Age Distribution ; Aged ; Aged, 80 and over ; Autoantibodies/blood ; Autoimmune Diseases/complications ; Autoimmune Diseases/epidemiology ; Blood Coagulation Factors/adverse effects ; Blood Coagulation Factors/therapeutic use ; China/epidemiology ; Databases, Factual ; Drug Therapy, Combination ; Factor VIII/immunology ; Female ; Glucocorticoids/therapeutic use ; Hemophilia A/epidemiology ; Hemophilia A/etiology ; Hemorrhage/drug therapy ; Hemorrhage/epidemiology ; Hemorrhage/etiology ; Hemostatics/therapeutic use ; Humans ; Immunosuppressive Agents/therapeutic use ; Male ; Middle Aged ; Neoplasms/complications ; Neoplasms/epidemiology ; Recurrence ; Registries ; Remission Induction ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł :
Bleeding and bruising in Osteogenesis Imperfecta: International Society on Thrombosis and Haemostasis bleeding assessment tool and haemostasis laboratory assessment in 22 individuals.
Autorzy :
Gooijer K; Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
Rondeel JMM; Department of Clinical Chemistry, Isala Hospital, Zwolle, The Netherlands.
van Dijk FS; Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.; North West Thames Regional Genetics Service, Ehlers-Danlos Syndrome National Diagnostic Service London, North West Health Care University NHS Trust, Harrow, Middlesex, UK.
Harsevoort AGJ; Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
Janus GJM; Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
Franken AAM; Expert Centre for adults with Osteogenesis Imperfecta, Isala Hospital, Zwolle, The Netherlands.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Nov; Vol. 187 (4), pp. 509-517. Date of Electronic Publication: 2019 Jul 14.
Typ publikacji :
Journal Article
MeSH Terms :
Contusions/*diagnosis
Hemorrhage/*diagnosis
Osteogenesis Imperfecta/*pathology
Adult ; Blood Coagulation Disorders ; Contusions/etiology ; Cross-Sectional Studies ; Female ; Fibrinolysis ; Hemorrhage/etiology ; Humans ; Male ; Pilot Projects ; Young Adult
Czasopismo naukowe
Tytuł :
Characterisation of a new clinical presentation of chronic lymphocytic leukaemia: symptomatic bronchial involvement, a study from the FILO group.
Autorzy :
Nudel M; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Baran-Marszak F; Bobigny: Hématologie, CHU Avicennes, Bobigny, France.
Bossard JB; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Dubois R; Anatomopathologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Dapvril H; Radiologie Thoracique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Dupuis J; Hématologie Clinique, CHU Henri Mondor, Créteil, France.
Laribi K; Hématologie Clinique, Centre Hospitalier Le Mans, Le Mans, France.
Bay JO; Hématologie Clinique, Centre Hospitalier Universitaire de Clermont-Ferrand, Clermont Ferrand, France.
Tomowiak C; Hématologie Clinique, Centre Hospitalier Universitaire Poitiers, Poitiers, France.
Dreyfus B; Hématologie Clinique, Centre Hospitalier Universitaire Poitiers, Poitiers, France.
Lepretre S; Hématologie Clinique, Centre Hospitalier Universitaire Rouen, Rouen, France.
Demarquette H; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Wallyn F; Pneumologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Wemeau L; Pneumologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Wemeau M; Hématologie Clinique, Centre Hospitalier de Roubaix, Roubaix, France.
Poulain S; Laboratoire D'Hématologie, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Morschhauser F; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Cymbalista F; Bobigny: Hématologie, CHU Avicennes, Bobigny, France.
Herbaux C; Hématologie Clinique, Centre Hospitalier Régional Universitaire de Lille, Lille, France.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Sep; Vol. 186 (5), pp. e126-e130. Date of Electronic Publication: 2019 May 22.
Typ publikacji :
Letter
MeSH Terms :
Leukemia, Lymphocytic, Chronic, B-Cell/*complications
Aged ; Aged, 80 and over ; Female ; Humans ; Leukemia, Lymphocytic, Chronic, B-Cell/pathology ; Male ; Middle Aged ; Retrospective Studies
Opinia redakcyjna
Tytuł :
Towards a better understanding of monoclonal gammopathy of renal significance.
Autorzy :
Bianchi G; Department of Medical Oncology, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA.
Richardson PG; Department of Medical Oncology, LeBow Institute for Myeloma Therapeutics and Jerome Lipper Multiple Myeloma Center, Harvard Medical School, Dana Farber Cancer Institute, Boston, MA, USA.
Pokaż więcej
Źródło :
British journal of haematology [Br J Haematol] 2019 Sep; Vol. 186 (5), pp. 653-654. Date of Electronic Publication: 2019 May 28.
Typ publikacji :
Editorial; Comment
MeSH Terms :
Monoclonal Gammopathy of Undetermined Significance*
Paraproteinemias*
Humans ; Kidney
Opinia redakcyjna
    Wyświetlanie 1-15 z 15

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies